[{"address1": "301 Carlson Parkway", "address2": "Suite 210", "city": "Minneapolis", "state": "MN", "zip": "55305", "country": "United States", "phone": "763 496 5454", "website": "https://www.diamedica.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dietrich John Pauls MBA", "age": 53, "title": "President, CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 917475, "exercisedValue": 0, "unexercisedValue": 1182125}, {"maxAge": 1, "name": "Mr. Scott  Kellen CPA", "age": 59, "title": "CFO & Corporate Secretary", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 539434, "exercisedValue": 0, "unexercisedValue": 310993}, {"maxAge": 1, "name": "Dr. Ambarish  Shah Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dominic R. Cundari", "age": 73, "title": "Chief Commercial Officer", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alex  Aimetti Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Julie  Krop M.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 2, "overallRisk": 4, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.22, "open": 7.23, "dayLow": 7.06, "dayHigh": 7.6698, "regularMarketPreviousClose": 7.22, "regularMarketOpen": 7.23, "regularMarketDayLow": 7.06, "regularMarketDayHigh": 7.6698, "payoutRatio": 0.0, "beta": 1.324, "forwardPE": -10.310811, "volume": 776169, "regularMarketVolume": 776169, "averageVolume": 394547, "averageVolume10days": 573370, "averageDailyVolume10Day": 573370, "bid": 7.55, "ask": 7.7, "bidSize": 6, "askSize": 6, "marketCap": 397350880, "fiftyTwoWeekLow": 3.19, "fiftyTwoWeekHigh": 7.68, "allTimeHigh": 44.94, "allTimeLow": 0.814, "fiftyDayAverage": 6.7546, "twoHundredDayAverage": 5.242075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 342298848, "profitMargins": 0.0, "floatShares": 24392031, "sharesOutstanding": 52077439, "sharesShort": 4119047, "sharesShortPriorMonth": 4236321, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0797, "heldPercentInsiders": 0.26275998, "heldPercentInstitutions": 0.45053002, "shortRatio": 16.65, "shortPercentOfFloat": 0.115, "impliedSharesOutstanding": 52077439, "bookValue": 0.991, "priceToBook": 7.6992936, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -31926000, "trailingEps": -0.71, "forwardEps": -0.74, "lastSplitFactor": "1:20", "lastSplitDate": 1542240000, "enterpriseToEbitda": -10.2, "52WeekChange": 0.5627706, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 7.63, "targetHighPrice": 25.0, "targetLowPrice": 11.0, "targetMeanPrice": 15.5, "targetMedianPrice": 13.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 55318000, "totalCashPerShare": 1.062, "ebitda": -33560000, "totalDebt": 266000, "quickRatio": 10.55, "currentRatio": 10.673, "debtToEquity": 0.515, "returnOnAssets": -0.38334998, "returnOnEquity": -0.64116997, "freeCashflow": -17127876, "operatingCashflow": -27731000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DMAC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "firstTradeDateMilliseconds": 1344000600000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.63, "postMarketChange": 0.0, "regularMarketChange": 0.41, "regularMarketDayRange": "7.06 - 7.6698", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 394547, "fiftyTwoWeekLowChange": 4.44, "fiftyTwoWeekLowChangePercent": 1.3918495, "fiftyTwoWeekRange": "3.19 - 7.68", "fiftyTwoWeekHighChange": -0.049999714, "fiftyTwoWeekHighChangePercent": -0.0065103797, "fiftyTwoWeekChangePercent": 56.27706, "dividendDate": 1542240000, "earningsTimestamp": 1762981200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "earningsCallTimestampStart": 1763038800, "earningsCallTimestampEnd": 1763038800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.71, "epsForward": -0.74, "epsCurrentYear": -0.7175, "marketState": "CLOSED", "shortName": "DiaMedica Therapeutics Inc.", "hasPrePostMarketData": true, "priceEpsCurrentYear": -10.634147, "fiftyDayAverageChange": 0.87540007, "fiftyDayAverageChangePercent": 0.12960058, "twoHundredDayAverageChange": 2.3879251, "twoHundredDayAverageChangePercent": 0.45553052, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 5.67868, "regularMarketPrice": 7.63, "longName": "DiaMedica Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1763759404, "regularMarketTime": 1763758801, "exchange": "NCM", "messageBoardId": "finmb_4382397", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "DiaMedica Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]